0:00 - Introduction - Evolving Treatment Paradigm of Multiple Myeloma
02:13- Changing treatment scenario with new additions in the multiple myeloma armamentarium
07:19- MMRF’s strategic priorities
14:50- Scope of radio therapeutics like CLR 131 in myeloma treatment
21:01- Target patient population for CLR 131 clinical trials
22:57- Clinical Trial challenges faced by patients, researchers and treating doctors
28:34- Diversity and Inclusions in Multiple Myeloma Clinical Trials
37:38- MMRF’s programs Advancing Precision medicine CureCloud, MyDRUG and Commpass
44:31- Looking ahead to the future of Multiple Myeloma Management
In the past decade, the FDA has approved 13 new agents and 29 treatments for multiple myeloma, which have transformed the treatment paradigm for patients. The expanded treatment options have resulted in significantly improved outcomes. Two decades ago, the median survival was approximately 3 years, and now it is 8 to 10 years and can be even longer for many patients.
We are discussing the latest trends in multiple myeloma treatments and the next frontiers with Dr. Sikander Ailawadhi of Mayo Clinic, Anne Quinn Young of MMRF, Brian McMahon of SparkCures and Jennifer Ahlstrom of Myeloma Crowd Foundation.
This talk has been created by CureTalks.com, in association with Cellectar BioSciences to facilitate discussions for solutions, with a mission to heal the world through information and sharing of knowledge. At CureTalks we discuss groundbreaking medical research including a wide range of medical, health, and wellness issues, bringing together the doctors, researchers and patients on the same platform.
#multiplemyeloma #radiotherapeutics #MyelomaTreatment #MyelomaResearch, #CancerTreatment #MedicalAdvancements #PrecisionMedicine #CancerResearch
#MMRF (Multiple Myeloma Research Foundation) #PatientSupport #MedicalInnovation #DiseaseManagement #CancerAwareness #TherapeuticAdvances #HealthcareDiscussion
SUBSCRIBE!
kzitem.info?s...
LET'S CONNECT!
Facebook: / curetalks
Instagram: / cure_talk
Linkedin: www.linkedin.com/company/cure...
Twitter : / curetalks
Pinterest: / _saved
Multiple Myeloma Treatment Paradigm, Evolving Treatment Strategies for Multiple Myeloma, New Additions in Multiple Myeloma Armamentarium, MMRF's Strategic Priorities in Multiple Myeloma, Radiotherapeutics in Myeloma Treatment (e.g., CLR 131), Target Patient Population for CLR 131 Clinical Trials, Clinical Trial Challenges in Multiple Myeloma, Diversity and Inclusion in Myeloma Clinical Trials. Precision Medicine Programs in Multiple Myeloma (e.g., CureCloud, MyDRUG, Commpass), Future of Multiple Myeloma Management
SUBSCRIBE!
kzitem.info?s...
LET'S CONNECT!
Website: https: www.curetalks.com/
Facebook: / curetalks
Instagram: / cure_talks_tx
Linkedin: www.linkedin.com/company/cure...
Twitter : / curetalks
Pinterest: / _saved
Негізгі бет Evolving Treatment Paradigm of Multiple Myeloma
Пікірлер